1140 related articles for article (PubMed ID: 29757195)
1. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.
Serhan CN; Levy BD
J Clin Invest; 2018 Jul; 128(7):2657-2669. PubMed ID: 29757195
[TBL] [Abstract][Full Text] [Related]
2. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
3. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
4. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
Serhan CN; de la Rosa X; Jouvene C
J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
[TBL] [Abstract][Full Text] [Related]
5. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.
Serhan CN; Chiang N; Dalli J
Mol Aspects Med; 2018 Dec; 64():1-17. PubMed ID: 28802833
[TBL] [Abstract][Full Text] [Related]
6. Resolution of inflammation in oral diseases.
Eltay EG; Van Dyke T
Pharmacol Ther; 2023 Jul; 247():108453. PubMed ID: 37244405
[TBL] [Abstract][Full Text] [Related]
7. Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential.
Li QF; Hao H; Tu WS; Guo N; Zhou XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7442-7453. PubMed ID: 32706084
[TBL] [Abstract][Full Text] [Related]
8. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
Serhan CN
Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
[TBL] [Abstract][Full Text] [Related]
9. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
Serhan CN; Chiang N; Dalli J
Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
[TBL] [Abstract][Full Text] [Related]
10. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.
Serhan CN; Dalli J; Colas RA; Winkler JW; Chiang N
Biochim Biophys Acta; 2015 Apr; 1851(4):397-413. PubMed ID: 25139562
[TBL] [Abstract][Full Text] [Related]
11. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
[TBL] [Abstract][Full Text] [Related]
12. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
Tang S; Wan M; Huang W; Stanton RC; Xu Y
Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
[TBL] [Abstract][Full Text] [Related]
13. Specialized pro-resolving mediators in cardiovascular diseases.
Fredman G; Spite M
Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
[TBL] [Abstract][Full Text] [Related]
14. Pro-resolving lipid mediators are leads for resolution physiology.
Serhan CN
Nature; 2014 Jun; 510(7503):92-101. PubMed ID: 24899309
[TBL] [Abstract][Full Text] [Related]
15. Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.
Norling LV; Ly L; Dalli J
Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):145-152. PubMed ID: 28002074
[TBL] [Abstract][Full Text] [Related]
16. The biosynthetic pathways of the protectins.
Stenvik Haatveit Å; Hansen TV
Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106787. PubMed ID: 37806439
[TBL] [Abstract][Full Text] [Related]
17. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
Serhan CN; Chiang N
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751
[TBL] [Abstract][Full Text] [Related]
18. Protectins: Their biosynthesis, metabolism and structure-functions.
Vidar Hansen T; Serhan CN
Biochem Pharmacol; 2022 Dec; 206():115330. PubMed ID: 36341938
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.
Das UN
Lipids Health Dis; 2016 Jan; 15():11. PubMed ID: 26762544
[TBL] [Abstract][Full Text] [Related]
20. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.
Chiang N; Serhan CN
Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
